These techniques also enable quantification of the tumor mast cell mass (allelic load) by expressing the allelic fraction of the circulating or medullary KIT D816V mutation, in particularly to monitor possible cytoreductive treatments (cladribine, TKIs) [28, 29]. Here, KIT is linked to neoplasm.